: Beta-blockers represent a key treatment pillar for reducing mortality and morbidity in patients with myocardial infarction (MI) and stable heart failure with a reduced ejection fraction (HFrEF) [...].
Do Beta-Blockers Really Matter in Patients with Myocardial Infarction Without Left Ventricular Systolic Dysfunction? Comment on Sabina et al. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Clin. Med. 2025, 14, 150
Cesaro, Arturo;Calabrò, Paolo
2025
Abstract
: Beta-blockers represent a key treatment pillar for reducing mortality and morbidity in patients with myocardial infarction (MI) and stable heart failure with a reduced ejection fraction (HFrEF) [...].File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
